Naylor Stuart
CHIEF SCI OFCR, OPHTHALMOLOGY at MGTX
- Sold, on record
- $2.2M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Jul 7, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MGTXMeiraGTx Holdings plcCHIEF SCI OFCR, OPHTHALMOLOGY
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale MGTXPlan not statedJan 5 2021
Sold 12,000 shares at $15.37 ($184k)
Naylor Stuart, Chief Development Officer
Sold 2.7% of holdings ($6.9M position)438,017 shares left1.4x usual sizeFiling
- 2 Form 4 sale MGTXPlan not statedApr 29 +114 days
Sold 5,177 shares at $15.11 ($78k)
Naylor Stuart, Chief Development Officer
Sold 1.2% of holdings ($6.6M position)432,840 shares left0.5x usual sizeFiling
- 3 Form 4 sale MGTXPlan not statedJun 8 +40 days
Sold 6,082 shares at $15.01 ($91k)
Naylor Stuart, Chief Development Officer
Sold 1.4% of holdings ($6.5M position)426,017 shares left0.7x usual sizeFiling
- 4 Form 4 sale MGTXPlan not statedJul 13 +35 days
Sold 2,610 shares at $15.04 ($39k)
Naylor Stuart, Chief Development Officer
Sold 0.6% of holdings ($6.4M position)423,407 shares left0.4x usual sizeFiling
- 5 Form 4 sale MGTXPlan not statedJul 20 +7 days
Sold 9,390 shares at $15.06 ($141k)
Naylor Stuart, Chief Development Officer
Sold 2.2% of holdings ($6.4M position)414,017 shares left1.5x usual sizeFiling
- 6 Form 4 sale MGTXPlan not statedOct 18 +90 days
Sold 12,000 shares at $17.95 ($215k)
Naylor Stuart, Chief Development Officer
Sold 2.9% of holdings ($7.4M position)402,017 shares left1.6x usual sizeFiling
- 7 Form 4 sale MGTXRoutineApr 7 +1632 days
Sold 27,661 shares at $9.36 ($259k)
Naylor Stuart, CHIEF DEV. OFFICER
10b5-1 planSold 4% of holdings ($6.5M position)668,505 shares leftFirst sale on recordFiling
- 8 Form 4 sale MGTXRoutineJul 7 +91 days
Sold 27,659 shares at $14.80 ($409k)
Naylor Stuart, CHIEF SCI OFCR, OPHTHALMOLOGY
10b5-1 planSold 4.1% of holdings ($9.9M position)640,846 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | MGTX | CHIEF SCI OFCR, OPHTHALMOLOGY | Form 4 sale | 27,659 | $409k | 4.1% | Routine | SEC |
| Apr 7, 2026 | MGTX | CHIEF DEV. OFFICER | Form 4 sale | 27,661 | $259k | 4.0% | Routine | SEC |
| Oct 18, 2021 | MGTX | Chief Development Officer | Form 4 sale | 12,000 | $215k | 2.9% | Plan not stated | SEC |
| Jul 20, 2021 | MGTX | Chief Development Officer | Form 4 sale | 9,390 | $141k | 2.2% | Plan not stated | SEC |
| Jul 13, 2021 | MGTX | Chief Development Officer | Form 4 sale | 2,610 | $39k | 0.6% | Plan not stated | SEC |
| Jun 8, 2021 | MGTX | Chief Development Officer | Form 4 sale | 6,082 | $91k | 1.4% | Plan not stated | SEC |
| Apr 29, 2021 | MGTX | Chief Development Officer | Form 4 sale | 5,177 | $78k | 1.2% | Plan not stated | SEC |
| Jan 5, 2021 | MGTX | Chief Development Officer | Form 4 sale | 12,000 | $184k | 2.7% | Plan not stated | SEC |
| Nov 10, 2020 | MGTX | Chief Development Officer | Form 4 sale | 3,739 | $56k | 0.8% | Plan not stated | SEC |
| Nov 9, 2020 | MGTX | Chief Development Officer | Form 4 sale | 8,794 | $132k | 1.9% | Plan not stated | SEC |
| Oct 5, 2020 | MGTX | Chief Development Officer | Form 4 sale | 301 | $5k | 0.1% | Plan not stated | SEC |
| Jul 21, 2020 | MGTX | Chief Development Officer | Form 4 sale | 10,054 | $151k | 2.1% | Plan not stated | SEC |
| May 11, 2020 | MGTX | Chief Development Officer | Form 4 sale | 11,304 | $174k | 2.3% | Plan not stated | SEC |
| Apr 20, 2020 | MGTX | Chief Development Officer | Form 4 sale | 696 | $10k | 0.1% | Plan not stated | SEC |
| Feb 19, 2020 | MGTX | Chief Development Officer | Form 4 sale | 12,000 | $216k | 2.4% | Plan not stated | SEC |